SINGAPORE (Apr 26): Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group which also owns the Ocean Health brand of supplements, has lodged a preliminary offer document with Singapore Exchange (SGX) to list on its Catalist Board in 2018.

Hyphens Pharma incorporated in Dec 2017 as a private company, and on Apr 20 this year was converted into a public limited company following a restructuring exercise.  

Through its wholly-owned subsidiary Pan-Malayan Pharmaceuticals, the group engages in the wholesale of pharmaceuticals and medical supplies in Singapore via both the conventional business model of tele-sales and sales representatives, as well as an online B2B platform at www.pom.com.sg.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook